Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression.
Dahlhoff J, Manz H, Steinfatt T, Delgado-Tascon J, Seebacher E, Schneider T, Wilnit A, Mokhtari Z, Tabares P, Böckle D, Rasche L, Martin Kortüm K, Lutz MB, Einsele H, Brandl A, Beilhack A.
Dahlhoff J, et al. Among authors: bockle d.
Leukemia. 2022 Mar;36(3):790-800. doi: 10.1038/s41375-021-01422-y. Epub 2021 Sep 28.
Leukemia. 2022.
PMID: 34584204
Free PMC article.